5 Results for "

activated B Cell-like (ABC)

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "activated B Cell-like (ABC)" in MCE Product Catalog:

Cat. No.: HY-160698
CAS No.: 2661481-41-8
Synonyms: SGR-1505
Target:  

MALT1 Apoptosis

Research Areas:  

Cancer

SGR-1505 is an oral small molecule MALT1 inhibitor with anti-proliferative and antitumor activity.SGR-1505 inhibits MALT1 enzymatic activity to modulate NF-κB pathway gene expression.SGR-1505 induces modulation of cell cycle, DNA damage, and apoptosis-related genes in in vivo tumor samples.SGR-1505 exerts tumorostatic and regressive activity in ABC-DLBCL xenograft models.SGR-1505 can be used for the research of activated B cell-like diffuse large B cell lymphoma, non-Hodgkin B-cell lymphomas, chronic lymphocytic leukemia, and mature B cell neoplasms .
loading...
    loading...
Cat. No.: HY-117622
CAS No.: 1388894-17-4
Target:  

IRAK

Research Areas:  

Inflammation/Immunology Cancer

ND-2110 is a selective IRAK4 inhibitor (Ki: 7.5 nM). ND-2110 binds to the ATP pocket of IRAK4. ND-2110 targets the subset of activated B cell-like (ABC) subtype of diffuse large B cell lymphoma (DLBCL) cell lines with MYD88 L265P mutations,. ND-2110 inhibits LPS-induced TNF production, alleviates collagen-induced arthritis, and blocks gout formation in mouse models .
loading...
    loading...
Cat. No.: HY-179075
Target:  

PROTACs BCL6 IKZF Family

Research Areas:  

Cancer

PROTAC BCL6/IKZF1/3 Degrader-1 is a selective and orally active BCL6 and IKZF1/3 PROTAC degrader. PROTAC BCL6/IKZF1/3 Degrader-1 exhibits superior antiproliferative effects in various germinal center B-cell-like (GCB) and activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) cell lines. PROTAC BCL6/IKZF1/3 Degrader-1 can be used for the research of cancer, such as lymphoma .
loading...
    loading...
Cat. No.: HY-146072
CAS No.: 3032742-74-5
Target:  

IRAK

Research Areas:  

Cancer

IRAK4-IN-11 (compound 6) is a potent IRAK4 inhibitor with an IC50 of 0.008 µM. IRAK4-IN-11 shows cell pIRAK4 potencies with an IC50 of 0.19 µM .
loading...
    loading...
Cat. No.: HY-146073
Target:  

IRAK

Research Areas:  

Cancer

IRAK4-IN-12 (compound 37) is a potent IRAK4 inhibitor with an IC50 of 0.015 µM. IRAK4-IN-12 shows cell pIRAK4 potencies with an IC50 of 0.5 µM .
loading...
    loading...